HomeME • NASDAQ
add
23andMe Holding Co.
Previous close
$3.23
Day range
$2.99 - $3.21
Year range
$2.66 - $20.20
Market cap
74.94M USD
Avg Volume
404.88K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
(USD) | Sep 2024info | Y/Y change |
---|---|---|
Revenue | 44.07M | -11.86% |
Operating expense | 81.33M | -17.18% |
Net income | -59.10M | 21.48% |
Net profit margin | -134.11 | 10.91% |
Earnings per share | — | — |
EBITDA | -54.96M | 21.06% |
Effective tax rate | 0.07% | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Sep 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 126.60M | -50.62% |
Total assets | 318.94M | -60.19% |
Total liabilities | 217.01M | 23.31% |
Total equity | 101.93M | — |
Shares outstanding | 26.12M | — |
Price to book | 0.82 | — |
Return on assets | -42.89% | — |
Return on capital | -75.30% | — |
Cash Flow
Net change in cash
(USD) | Sep 2024info | Y/Y change |
---|---|---|
Net income | -59.10M | 21.48% |
Cash from operations | -40.93M | 28.34% |
Cash from investing | -2.70M | 2.63% |
Cash from financing | 260.00K | -83.68% |
Net change in cash | -43.37M | 25.18% |
Free cash flow | -12.82M | 59.90% |
About
23andMe Holding Co. is an American personal genomics and biotechnology company based in South San Francisco, California. It is best known for providing a direct-to-consumer genetic testing service in which customers provide a saliva sample that is laboratory analysed, using single nucleotide polymorphism genotyping, to generate reports relating to the customer's ancestry and genetic predispositions to health-related topics. The company's name is derived from the 23 pairs of chromosomes in a diploid human cell.
Founded in 2006, 23andMe soon became the first company to begin offering autosomal DNA testing for ancestry, which all other major companies now use. Its saliva-based direct-to-consumer genetic testing business was named "Invention of the Year" by Time in 2008.
The company had a previously fraught relationship with the United States Food and Drug Administration due to its genetic health tests; as of October 2015, DNA tests ordered in the US include a revised health component, per FDA approval. 23andMe has been selling a product with both ancestry and health-related components in Canada since October 2014, and in the UK since December 2014. Wikipedia
Founded
Apr 2006
Headquarters
Website
Employees
571